Dr. Michael P. Menden
Junior Group Leader“Our research focus is studying multi-omics landscapes of complex diseases, understanding their mechanisms and suggesting novel treatment strategies based on machine learning and biostatistics.”
“Our research focus is studying multi-omics landscapes of complex diseases, understanding their mechanisms and suggesting novel treatment strategies based on machine learning and biostatistics.”
Translational Computational Pharmacogenomics
The mission of our research group is to develop biostatistical and machine learning frameworks applied to biomedical data, to retrieve insights in the aetiology of complex diseases and identify patient stratifications. For this, we explore deep molecular characterised biomedical datasets, environmental factors, and tailor our models depending on disease specific knowledge gained through literature and data driven analyses, thus empowering the next generation of precision medicine.
More
Dr. Michael P. Menden is a Junior Group Leader at the Computational Health Center, Helmholtz Munich since 2019. He is leading the Menden Lab and is Head of the DZD Computational Biology Unit. Dr. Menden became an ERC Starting Grant Laureate in 2020, and was awarded the Rising Star in Drug Discovery Award by the University of Cardiff in 2022. Previously, Dr. Menden worked as Senior Scientist in Oncology Bioinformatics, AstraZeneca, UK. He was a PhD student and postdoctoral fellow at EMBL-EBI, UK. His PhD was awarded in Computational Biology by the University of Cambridge, UK in 2016. In 2017, Dr. Menden was appointed an Honorary Lecturer position at the University of Sheffield, UK. Since 2019, Dr. Menden also became a lecturer in the Technical University of Munich (TUM) and Ludwig Maximilian University (LMU).
Computational Biomedicine
drug discoveryBig Dataprecision medicinedrug target identificationdrug repurposingmachine learningbiostatisticsdrug high-throughput screens
Professional Background
Principal Investigator, Computational Biomedicine Group
Institute of Computational Biology (ICB), Helmholtz Munich, Germany
Head of DZD Computational Biology Unit
German Center for Diabetes Research, Helmholtz Munich, Germany
Senior Scientist in Oncology Bioinformatics
Innovative Medicines and Early Development (IMED) Oncology, AstraZeneca, UK
Short-Term Postdoctoral Fellow in Saez-Rodriguez Lab
University Hospital Aachen & RWTH Aachen, Germany
PhD student in Saez-Rodriguez Lab
EMBL-EBI, UK
Visiting Researcher in Sorger Lab
Department of Systems Biology, Harvard Medical School (HMS), USA
Honors and Awards
2022
McGuigan Drug Discovery Rising Star Prize, Cardiff University, UK2020
ERC Starting Grant2018
AstraZeneca Award for driving successful external oncology collaborations, UK2017
AstraZeneca Leadership Team Recognition Award, UK2013
Sage Bionetworks Young Investigator Award, Sage Bionetworks, USA2011
EMBL-EBI Pre-Doctoral Fellowship, UK2008
ERASMUS Scholarship, DAAD, Germany
Publications
Read more2024 Scientific Article in Diabetes/Metabolism Research and Reviews